Product Information
BUPRENORPHINE 8 MG TABLET SL is a generic product labeled by PAI Holdings LLC, priced at $0.5616 per EA under NDC 00121203830. Its NADAC has been published 121 times since Mar 6, 2024.
Strength
8 mg/1
Manufacturer
PAI Holdings LLCNDC
00121203830
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090622On Market Since
10/12/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 8 MG TABLET SL has been published 121 times since Mar 6, 2024, and over the history we have for it it has declined 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5616 per EA |
|---|---|
| All-time high | $0.8994 (Sep 11, 2024) |
| All-time low | $0.5567 (Apr 22, 2026) |
| 52-week high | $0.7497 |
| 52-week low | $0.5567 |
| Median price | $0.7127 |
| Average price | $0.7193 |
| Largest weekly change | +27.5% (Aug 21, 2024) |
| Weeks tracked | 121 |
| Tracking since | Mar 6, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 8 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 8 MG TABLET SL, manufactured by PAI Holdings LLC, is $0.5616 per EA (NDC 00121203830), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 8 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 8 MG TABLET SL has declined 36.6%. It has been tracked across 121 weekly CMS publications since Mar 6, 2024.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 8 MG TABLET SL?
Since Mar 6, 2024, the NADAC for BUPRENORPHINE 8 MG TABLET SL has ranged from a low of $0.5567 (Apr 22, 2026) to a high of $0.8994 (Sep 11, 2024), with a median of $0.7127 per EA.
Are there cheaper alternatives to BUPRENORPHINE 8 MG TABLET SL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUPRENORPHINE 8 MG TABLET SL, but none are currently priced below it.
Who manufactures BUPRENORPHINE 8 MG TABLET SL?
BUPRENORPHINE 8 MG TABLET SL (NDC 00121203830) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification